ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990

ONS Continue Growth, Associate Category Defeated Again

May 15, 1987

Clinical Trials Issues: Maryland Law Mandates Insurance Coverage Of Patient Care Costs In Clinical Trials

July 3, 1998

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions

October 11, 2002